ADIM
RNST icon

Alpha DNA Investment Management’s Renasant Corp RNST Stock Holding History

Alpha DNA Investment Management’s Portfolio RNST Stock Details RNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,678
Closed -$552K – 196
2022
Q3 		$552K Buy
+17,678
New +$575K 0.46% 103

Other funds holding RNST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Alpha DNA Investment Management's RNST Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Renasant Corp (RNST) in Q4 2022, closing a stake of 17,678 shares — an estimated $552K sold.

Alpha DNA Investment Management first reported a position in RNST in Q3 2022 and held it in 1 quarter. The position peaked at $552K in Q3 2022. 214 funds tracked by Wall St. Rank hold RNST as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining Renasant Corp position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 17,678 Renasant Corp shares in Q4 2022, an estimated $552K.
  • Alpha DNA Investment Management first reported a position in Renasant Corp in Q3 2022 and held it in 1 quarter.
  • Alpha DNA Investment Management's Renasant Corp position peaked at $552K in Q3 2022.
  • 214 funds tracked by Wall St. Rank held Renasant Corp as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.